techbullion.com

How Clintex is Transforming the Healthcare Industry

By Angela Scott-Briggs·Published August 20, 2018·Updated September 28, 2026·Blockchain

clintex clinical trial

The Clinical trial industry, with its estimated USD 350 billion worth, is the most important part of the healthcare industry. Over the years, the trials have been expanded and have become complex, often employing thousands of man-hours and different organizations and individuals. Trials are divided into four phases: Further reading: How AENCO Is Transforming The Healthtech Industry With Blockchain Technology.

The cost of these trials can be judged through Phase 3 financial implications. A Phase 3 trial can cost anywhere from USD 30 million to 70 million. Most of the times, repeated trials are required and that can drive up the cost further.

ClinTex’s CTi

In all the phases of trials, there are multiple parties involved. From pharmaceuticals to laboratories, from doctors to test volunteer. At each level, there is an exchange of data and money. ClinTex is an Ethereum based blockchain platform that leverages the power of decentralization and artificial intelligence to fine-tune the data collection and processing. Through this, the platform delivers increased efficiency. Considering that an average clinical trial costs $ 15 million, even a small percentage of decrease will result in significant savings.

The platform transforms the industry through its dedicated Clinical Trial intelligence board (CTi). The CTi offers some improvements that do not take lesser time, but result in decreased costs:

ClinTex Specific Apps

Apart from these generic properties of blockchain that will essentially bring about a change in the healthcare industry, the platform has developed task-specific decentralized applications that will bring increased efficiency in terms of time consumed and cost required for trials:

ClinTex, with its CTi, will change the healthcare industry by bringing in a system far more efficient than current standards, thereby reducing trial costs and eventually, cheaper medication.